Return to Trial Database

BTCRC-GU19-404

A Single Arm, Phase I/II Trial of Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men with Localized, High Risk Prostate Cancer Big Ten Cancer Research Consortium BTCRC-GU19-404

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial BTCRC-GU19-404 being conducted in.

No data was found